156 related articles for article (PubMed ID: 26417299)
1. Serum protein electrophoresis under effective control of HIV-1 disease progression.
Adedeji AL; Adenikinju RO; Ajele JO; Olawoye TL
EXCLI J; 2014; 13():761-71. PubMed ID: 26417299
[TBL] [Abstract][Full Text] [Related]
2. Serum protein electrophoresis patterns in human immunodeficiency virus-infected individuals not on antiretroviral treatment.
Zemlin AE; Ipp H; Maleka S; Erasmus RT
Ann Clin Biochem; 2015 May; 52(Pt 3):346-51. PubMed ID: 25487599
[TBL] [Abstract][Full Text] [Related]
3. Oligoclonal Bands of Immunoglobulins in Serum Leading to Diagnosis of Human Immunodeficiency Virus 1 Infection.
Soong J; Riley R; Mcpherson R
Am J Clin Pathol; 2016 Feb; 145(2):277-81. PubMed ID: 26834125
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function.
Jacobson MA; Khayam-Bashi H; Martin JN; Black D; Ng V
J Acquir Immune Defic Syndr; 2002 Dec; 31(5):472-7. PubMed ID: 12473834
[TBL] [Abstract][Full Text] [Related]
5. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
6. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
7. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
8. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
9. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
10. Better preserved immune responses after immunization with rgp 160 in HIV-1 infected patients treated with highly active antiretroviral therapy than in untreated patients with similar CD4 levels during at 2 years' follow-up.
Hejdeman B; Leandersson AC; Fredriksson EL; Sandström E; Wahren B; Bratt G
HIV Med; 2003 Apr; 4(2):101-10. PubMed ID: 12702130
[TBL] [Abstract][Full Text] [Related]
11. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
13. Analytical sensitivity and diagnostic performance of serum protein electrophoresis on the HYDRAGEL 30 PROTEIN(E) β1-β2 Sebia Hydrasys system.
Tsui AKY; Thomas D; Hunt A; Estey M; Christensen CL; Higgins T; Sandhu I; Rodriguez-Capote K
Clin Biochem; 2018 Jan; 51():80-84. PubMed ID: 28916438
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
15. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.
Resino S; Galán I; Pérez A; León JA; Seoane E; Gurbindo D; Muñoz-Fernandez MA
Clin Exp Immunol; 2004 Sep; 137(3):570-7. PubMed ID: 15320908
[TBL] [Abstract][Full Text] [Related]
16. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
17. Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.
Sutherland R; Yang H; Scriba TJ; Ondondo B; Robinson N; Conlon C; Suttill A; McShane H; Fidler S; McMichael A; Dorrell L
AIDS; 2006 Apr; 20(6):821-9. PubMed ID: 16549965
[TBL] [Abstract][Full Text] [Related]
18. Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
Gopalakrishnan V; Bose E; Nair U; Cheng Y; Ghebremichael M
BMC Infect Dis; 2020 Oct; 20(1):756. PubMed ID: 33059622
[TBL] [Abstract][Full Text] [Related]
19. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
Aiuti F; Mezzaroma I
AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
[TBL] [Abstract][Full Text] [Related]
20. Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Ballesteros C; Martinez P; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2005 Apr; 38(4):373-81. PubMed ID: 15764953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
